Search research articles
Contact Us
Filters
Showing results (1-10 of 63) with videos related to
Page
of 7
Sort By:
Pediatric Blood & Cancer
|
December 14, 2011
Inflammation: what role in pediatric cancer?
Daniel A Morgenstern, John Anderson
Expert Review of Anticancer Therapy
|
February 1, 2006
MYCN deregulation as a potential target for novel therapies in rhabdomyosarcoma
Daniel A Morgenstern, John Anderson
Journal of Pediatric Hematology/Oncology
|
May 25, 2013
Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy
Daniel A Morgenstern, Sylvain Baruchel, Meredith S Irwin
Progress in Brain Research
|
November 21, 2002
Chondroitin sulphate proteoglycans in the CNS injury response
Daniel A Morgenstern, Richard A Asher, James W Fawcett
The American Journal of Surgical Pathology
|
July 31, 2009
PAX5 expression in rhabdomyosarcoma
Daniel A Morgenstern, Sian Gibson, Neil J Sebire, et al.
Pediatric Blood & Cancer
|
August 5, 2009
Clinical and pathological features of paediatric malignant rhabdoid tumours
Daniel A Morgenstern, Sian Gibson, Tanya Brown, et al.
The Annals of Otology, Rhinology, and Laryngology
|
July 13, 2023
Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis
Cal H Robinson, Michael Hart-Matyas, Daniel A Morgenstern, et al.
Journal of Pediatric Hematology/Oncology
|
October 11, 2019
The Role of Surgery in High-risk Neuroblastoma
Anne L Ryan, Adesola Akinkuotu, Agostino Pierro, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 17, 2022
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again
Adrienne H Long, Daniel A Morgenstern, Amaury Leruste, et al.
American Journal of Clinical Pathology
|
February 16, 2010
PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies
Daniel A Morgenstern, Fyeza Hasan, Sian Gibson, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 63) with videos related to
Sort By:
Page
of 7
Pediatric Blood & Cancer
|
December 14, 2011
Inflammation: what role in pediatric cancer?
Daniel A Morgenstern, John Anderson
Expert Review of Anticancer Therapy
|
February 1, 2006
MYCN deregulation as a potential target for novel therapies in rhabdomyosarcoma
Daniel A Morgenstern, John Anderson
Journal of Pediatric Hematology/Oncology
|
May 25, 2013
Current and future strategies for relapsed neuroblastoma: challenges on the road to precision therapy
Daniel A Morgenstern, Sylvain Baruchel, Meredith S Irwin
Progress in Brain Research
|
November 21, 2002
Chondroitin sulphate proteoglycans in the CNS injury response
Daniel A Morgenstern, Richard A Asher, James W Fawcett
The American Journal of Surgical Pathology
|
July 31, 2009
PAX5 expression in rhabdomyosarcoma
Daniel A Morgenstern, Sian Gibson, Neil J Sebire, et al.
Pediatric Blood & Cancer
|
August 5, 2009
Clinical and pathological features of paediatric malignant rhabdoid tumours
Daniel A Morgenstern, Sian Gibson, Tanya Brown, et al.
The Annals of Otology, Rhinology, and Laryngology
|
July 13, 2023
Renal Implications of Long-Term Systemic Bevacizumab for Recurrent Respiratory Papillomatosis
Cal H Robinson, Michael Hart-Matyas, Daniel A Morgenstern, et al.
Journal of Pediatric Hematology/Oncology
|
October 11, 2019
The Role of Surgery in High-risk Neuroblastoma
Anne L Ryan, Adesola Akinkuotu, Agostino Pierro, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 17, 2022
Checkpoint Immunotherapy in Pediatrics: Here, Gone, and Back Again
Adrienne H Long, Daniel A Morgenstern, Amaury Leruste, et al.
American Journal of Clinical Pathology
|
February 16, 2010
PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies
Daniel A Morgenstern, Fyeza Hasan, Sian Gibson, et al.
Page
of 7